Twist Bioscience Corp

0ME

Company Profile

  • Business description

    Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

  • Contact

    681 Gateway Boulevard
    South San FranciscoCA94080
    USA

    T: +1 800 719-0671

    https://www.twistbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 September 2026

    Employees

    979

Stocks News & Analysis

stocks

Navigating the ASX dividend landscape in 2026

Dividend yields are well below the 10-year average. Here’s how to navigate lower yields in 2026.
stocks

Meta stock has struggled amid AI spending concerns. Is it a buy?

Meta stock has lost ground as investors raise concern over capital expenditures and risky AI strategies.
stocks

Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth

We think Netflix stock is moderately overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,172.5012.400.14%
CAC 408,148.8979.720.99%
DAX 4024,856.47295.491.20%
Dow JONES (US)49,554.72477.490.97%
FTSE 10010,150.0511.960.12%
HKSE26,629.9644.900.17%
NASDAQ23,477.41252.591.09%
Nikkei 22553,688.89914.251.73%
NZX 50 Index13,556.87139.701.04%
S&P 5006,929.1153.490.78%
S&P/ASX 2008,848.7012.800.14%
SSE Composite Index4,122.585.640.14%

Market Movers